The Global Triple X Syndrome Management Industry is on a steady growth trajectory, driven by increasing awareness and diagnosis. According to a recent report by Future Market Insights (FMI), the market is expected to reach a valuation of US$268.83 million by 2033. This reflects a robust Compound Annual Growth Rate (CAGR) of 6% anticipated from …